急性淋巴细胞白血病中13q12.2缺失通过增强子劫持导致FLT3上调
本研究在5个患者队列共1418例B细胞前体急性淋巴细胞白血病中分析体细胞半合子13q12.2微缺失的致病作用,发现缺失位于FLT3的5'端并涉及PAN3位点,导致拓扑关联域边界和FLT3增强子丢失,引起FLT3启动子与远端增强子顺式相互作用增加及等位基因特异性FLT3上调。13q12.2缺失在高超二倍体亚型中富集(频率3.9% vs 其他B细胞前体急性淋巴细胞白血病0.5%)并在后续复发例中富集。
要点
- 13q12.2缺失位于FLT3的5'端并涉及PAN3位点,导致拓扑关联域边界和FLT3增强子丢失。
- 缺失引起FLT3启动子与远端增强子顺式相互作用增加,导致等位基因特异性FLT3上调。
- 13q12.2缺失在高超二倍体B细胞前体急性淋巴细胞白血病中频率3.9%,其他亚型0.5%。
核心结论
- 本研究描述了FLT3通过染色质重塑和增强子劫持上调参与白血病发生的新机制,进一步强调FLT3作为B细胞前体急性淋巴细胞白血病驱动基因的作用。
研究设计与样本
- 研究使用5个不同的患者队列,共包括1418例B细胞前体急性淋巴细胞白血病病例,分析体细胞半合子13q12.2微缺失的致病影响。
主要发现
- 13q12.2缺失发生在FLT3的5'端并涉及PAN3位点。
- 缺失导致拓扑关联域边界和FLT3增强子丢失,引起FLT3启动子与位于缺失断点远端的另一增强子之间顺式相互作用增加,伴随等位基因特异性FLT3表达上调,预期导致配体非依赖性受体激活和下游信号传导。
- 13q12.2缺失在高超二倍体B细胞前体急性淋巴细胞白血病亚型中富集,频率为3.9%,其他B细胞前体急性淋巴细胞白血病为0.5%。
- 13q12.2缺失在后续复发的病例中富集。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in the FMS-like tyrosine kinase 3 (FLT3) gene in 13q12.2 are among the most common driver events in acute leukemia, leading to increased cell proliferation and survival through activation of the phosphatidylinositol 3-kinase/AKT-, RAS/MAPK-, and STAT5-signaling pathways. In this study, we examine the pathogenetic impact of somatic hemizygous 13q12.2 microdeletions in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) using 5 different patient cohorts (in total including 1418 cases). The 13q12.2 deletions occur immediately 5' of FLT3 and involve the PAN3 locus. By detailed analysis of the 13q12.2 segment, we show that the deletions lead to loss of a topologically associating domain border and an enhancer of FLT3. This results in increased cis interactions between the FLT3 promoter and another enhancer located distally to the deletion breakpoints, with subsequent allele-specific upregulation of FLT3 expression, expected to lead to ligand-independent activation of the receptor and downstream signaling. The 13q12.2 deletions are highly enriched in the high-hyperdiploid BCP ALL subtype (frequency 3.9% vs 0.5% in other BCP ALL) and in cases that subsequently relapsed. Taken together, our study describes a novel mechanism of FLT3 involvement in leukemogenesis by upregulation via chromatin remodeling and enhancer hijacking. These data further emphasize the role of FLT3 as a driver gene in BCP ALL.
引用
- Yang M, Safavi S, Woodward EL, et al. 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking. Blood. 2020. PMID: 32384149. doi:10.1182/blood.2019004684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。